The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Paolo Palatini

Clinica Medica 4

University of Padova




Name/email consistency: high



  • Clinica Medica 4, University of Padova, Padova, Italy. 2001 - 2012
  • University of Michigan, USA. 2002


  1. Factors associated with glomerular hyperfiltration in the early stage of hypertension. Palatini, P., Dorigatti, F., Saladini, F., Benetti, E., Mos, L., Mazzer, A., Zanata, G., Garavelli, G., Casiglia, E. Am. J. Hypertens. (2012) [Pubmed]
  2. Cardiovascular effects of exercise in young hypertensives. Palatini, P. Int. J. Sports. Med (2012) [Pubmed]
  3. Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension. Palatini, P., Casiglia, E., Gąsowski, J., Głuszek, J., Jankowski, P., Narkiewicz, K., Saladini, F., Stolarz-Skrzypek, K., Tikhonoff, V., Van Bortel, L., Wojciechowska, W., Kawecka-Jaszcz, K. Vasc. Health. Risk. Manag (2011) [Pubmed]
  4. Resting heart rate as a predictor of body weight gain in the early stage of hypertension. Palatini, P., Mos, L., Santonastaso, M., Zanatta, N., Mormino, P., Saladini, F., Bortolazzi, A., Cozzio, S., Garavelli, G. Obesity. (Silver. Spring) (2011) [Pubmed]
  5. Effect of regular physical activity on carotid intima-media thickness. Results from a 6-year prospective study in the early stage of hypertension. Palatini, P., Puato, M., Rattazzi, M., Pauletto, P. Blood Press. (2010) [Pubmed]
  6. Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: results of a randomized, double-blind study. Palatini, P., Jung, W., Shlyakhto, E., Botha, J., Bush, C., Keefe, D.L. J. Hum. Hypertens (2010) [Pubmed]
  7. Regular physical activity prevents development of left ventricular hypertrophy in hypertension. Palatini, P., Visentin, P., Dorigatti, F., Guarnieri, C., Santonastaso, M., Cozzio, S., Pegoraro, F., Bortolazzi, A., Vriz, O., Mos, L. Eur. Heart J. (2009) [Pubmed]
  8. Cystatin C as predictor of microalbuminuria in the early stage of hypertension. Palatini, P., Benetti, E., Zanier, A., Santonastaso, M., Mazzer, A., Cozzio, S., Zanata, G., De Toni, R., Zaninotto, M. Nephron. Clin. Pract (2009) [Pubmed]
  9. The role of cardiac autonomic function in hypertension and cardiovascular disease. Palatini, P., Julius, S. Curr. Hypertens. Rep. (2009) [Pubmed]
  10. Elevated heart rate in cardiovascular diseases: a target for treatment? Palatini, P. Prog. Cardiovasc. Dis (2009) [Pubmed]
  11. CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. Palatini, P., Ceolotto, G., Ragazzo, F., Dorigatti, F., Saladini, F., Papparella, I., Mos, L., Zanata, G., Santonastaso, M. J. Hypertens. (2009) [Pubmed]
  12. Angiotensin II type 1 receptor gene polymorphism predicts development of hypertension and metabolic syndrome. Palatini, P., Ceolotto, G., Dorigatti, F., Mos, L., Santonastaso, M., Bratti, P., Papparella, I., Pessina, A.C., Semplicini, A. Am. J. Hypertens. (2009) [Pubmed]
  13. Validation of Microlife BP W100 wrist device assessed according to the European Society of Hypertension and the British Hypertension Society protocols. Palatini, P., Dorigatti, F., Bonso, E., Ragazzo, F. Blood. Press. Monit (2009) [Pubmed]
  14. Elevated heart rate: a "new" cardiovascular risk factor?. Palatini, P. Prog. Cardiovasc. Dis (2009) [Pubmed]
  15. Validation of the Microlife BP W200-1 wrist device for blood pressure measurement. Palatini, P., Dorigatti, F., Bonso, E., Ragazzo, F. Blood. Press. Monit (2008) [Pubmed]
  16. Heart rate as predictor of outcome. Palatini, P. Blood. Press. Monit (2008) [Pubmed]
  17. Exercise testing in asymptomatic subjects: from diagnostic test to prognostic tool?. Palatini, P. Eur. Heart J. (2008) [Pubmed]
  18. Ambulatory blood pressure and cardiovascular risk in chronic kidney disease. Palatini, P. Curr. Hypertens. Rep. (2008) [Pubmed]
  19. Ambulatory blood pressure monitoring in clinical practice: is being superior good enough?. Palatini, P. J. Hypertens. (2008) [Pubmed]
  20. Assessment of urinary albumin excretion might improve cardiovascular outcome in patients with hypertension. Palatini, P. Nature Clinical Practice. Nephrology (2008) [Pubmed]
  21. Association between coffee consumption and risk of hypertension. Palatini, P., Dorigatti, F., Santonastaso, M., Cozzio, S., Biasion, T., Garavelli, G., Pessina, A.C., Mos, L. Ann. Med. (2007) [Pubmed]
  22. Heart rate as an independent risk factor for cardiovascular disease: current evidence and basic mechanisms. Palatini, P. Drugs (2007) [Pubmed]
  23. Heart rate as a predictor of development of sustained hypertension in subjects screened for stage 1 hypertension: the HARVEST Study. Palatini, P., Dorigatti, F., Zaetta, V., Mormino, P., Mazzer, A., Bortolazzi, A., D'Este, D., Pegoraro, F., Milani, L., Mos, L. J. Hypertens. (2006) [Pubmed]
  24. Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy. Palatini, P., Benetos, A., Julius, S. Drugs (2006) [Pubmed]
  25. Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. Palatini, P., Benetos, A., Grassi, G., Julius, S., Kjeldsen, S.E., Mancia, G., Narkiewicz, K., Parati, G., Pessina, A.C., Ruilope, L.M., Zanchetti, A. J. Hypertens. (2006) [Pubmed]
  26. Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. Palatini, P., Mormino, P., Dorigatti, F., Santonastaso, M., Mos, L., De Toni, R., Winnicki, M., Dal Follo, M., Biasion, T., Garavelli, G., Pessina, A.C. Kidney Int. (2006) [Pubmed]
  27. Microalbuminuria, renal function and development of sustained hypertension: a longitudinal study in the early stage of hypertension. Palatini, P., Mormino, P., Mos, L., Mazzer, A., Dorigatti, F., Zanata, G., Longo, D., Garbelotto, R., De Toni, R., Graniero, G., Pessina, A.C. J. Hypertens. (2005) [Pubmed]
  28. Combination therapy in the management of hypertension: focus on angiotensin receptor blockers combined with diuretics. Palatini, P. J. Clin. Hypertens. (Greenwich) (2005) [Pubmed]
  29. Wrist blood pressure overestimates blood pressure measured at the upper arm. Palatini, P., Longo, D., Toffanin, G., Bertolo, O., Zaetta, V., Pessina, A.C. Blood. Press. Monit (2004) [Pubmed]
  30. Comparison of the effects on 24-h ambulatory blood pressure of valsartan and amlodipine, alone or in combination with a low-dose diuretic, in elderly patients with isolated systolic hypertension (Val-syst Study). Palatini, P., Mugellini, A., Spagnuolo, V., Santonastaso, M., Ambrosia, G.B., Caiazza, A., Malacco, E. Blood. Press. Monit (2004) [Pubmed]
  31. Prevalence and clinical significance of isolated ambulatory hypertension in young subjects screened for stage 1 hypertension. Palatini, P., Winnicki, M., Santonastaso, M., Mos, L., Longo, D., Zaetta, V., Dal Follo, M., Biasion, T., Pessina, A.C. Hypertension (2004) [Pubmed]
  32. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Palatini, P., Dorigatti, F., Mugellini, A., Spagnuolo, V., Varì, N., Ferrara, R., Bertocchi, F. Clin. Ther (2004) [Pubmed]
  33. Masked hypertension: how can the condition be detected?. Palatini, P. Blood. Press. Monit (2004) [Pubmed]
  34. The white-coat effect is unrelated to the difference between clinic and daytime blood pressure and is associated with greater reactivity to public speaking. Palatini, P., Palomba, D., Bertolo, O., Minghetti, R., Longo, D., Sarlo, M., Pessina, A.C. J. Hypertens. (2003) [Pubmed]
  35. Microalbuminuria in hypertension. Palatini, P. Curr. Hypertens. Rep. (2003) [Pubmed]
  36. Heritability of left atrial size in the Tecumseh population. Palatini, P., Amerena, J., Nesbitt, S., Valentini, M., Majahalme, S., Krause, L., Tikhonoff, V., Julius, S. Eur. J. Clin. Invest. (2002) [Pubmed]
  37. Too much of a good thing? A critique of overemphasis on the use of ambulatory blood pressure monitoring in clinical practice. Palatini, P. J. Hypertens. (2002) [Pubmed]
  38. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Palatini, P., Thijs, L., Staessen, J.A., Fagard, R.H., Bulpitt, C.J., Clement, D.L., de Leeuw, P.W., Jaaskivi, M., Leonetti, G., Nachev, C., O'Brien, E.T., Parati, G., Rodicio, J.L., Roman, E., Sarti, C., Tuomilehto, J. Arch. Intern. Med. (2002) [Pubmed]
  39. Limitations of ambulatory blood pressure monitoring. Palatini, P. Blood. Press. Monit (2001) [Pubmed]
  40. Reliability of ambulatory blood pressure monitoring. Palatini, P. Blood. Press. Monit (2001) [Pubmed]
WikiGenes - Universities